Astrocytoma
You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.
| Astrocytoma Classification and external resources | |
 | |
|---|---|
| Astrocytoma: Electron micrograph | |
| ICD-10 | C71. |
| ICD-9 | 191 |
| ICD-O: | M9400/3 |
| OMIM | 137800 |
| DiseasesDB | 29449 |
| eMedicine | med/2693 |
|
WikiDoc Resources for Astrocytoma | |
|
Articles | |
|---|---|
|
Most recent articles on Astrocytoma Most cited articles on Astrocytoma | |
|
Media | |
|
Powerpoint slides on Astrocytoma | |
|
Evidence Based Medicine | |
|
Clinical Trials | |
|
Ongoing Trials on Astrocytoma at Clinical Trials.gov Clinical Trials on Astrocytoma at Google
| |
|
Guidelines / Policies / Govt | |
|
US National Guidelines Clearinghouse on Astrocytoma
| |
|
Books | |
|
News | |
|
Commentary | |
|
Definitions | |
|
Patient Resources / Community | |
|
Patient resources on Astrocytoma Discussion groups on Astrocytoma Patient Handouts on Astrocytoma Directions to Hospitals Treating Astrocytoma Risk calculators and risk factors for Astrocytoma
| |
|
Healthcare Provider Resources | |
|
Causes & Risk Factors for Astrocytoma | |
|
Continuing Medical Education (CME) | |
|
International | |
|
| |
|
Businness | |
|
Experimental / Informatics | |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Phone:617-525-6884
Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
Overview
Astrocytomas are primary intracranial tumors derived from astrocytes cells of the brain. They may arise in the cerebral hemispheres, in the posterior fossa, in the optic nerve, and rarely, the spinal cord. The WHO has given a four point scale depending on the histologic grade of the tumor (see below). This article focuses on the well-differentiated (Grade 2) astrocytoma. For grade 1 and 4 astrocytomas, see respective article headings:
Pathogenesis
Well-differentiated astrocytomas constitute about 25 to 30% of cerebral gliomas. They have a predilection for the cerebrum, cerebellum, hypothalamus, pons, and optic nerve and chiasm. Although astrocytomas have many different histological characteristics, the most common type is the well-differentiated fibrillary astrocytoma. These tumors express glial fibrillary acidic protein (GFAP), which possibly functions as a tumor suppressor[1], and is a useful diagnostic marker in a tissue biopsy. [2]
Grading
Astrocytomas have great variation in their presentation. The World Health Organization acknowledges the following grading system for astrocytomas:
- Grade 1 — pilocytic astrocytoma - primarily pediatric tumor, with median age at diagnosis of 12
- Grade 2 — diffuse astrocytoma
- Grade 3 — anaplastic (malignant) astrocytoma
- Grade 4 — glioblastoma multiforme (most common)
In addition to these four tumor grades, astrocytomas may combine with oligodendrocytes to produce oligoastrocytoma. Unique astrocytoma variants have also been known to exist.
Symptoms
In almost half of the cases, the first symptom of an astrocytoma is the onset of a focal or generalized seizure. Between 60 to 75% of patients will have recurrent seizures in the course of their illness. Headache and signs of increased intracranial pressure (headache, vomiting) usually present late in the disease course.
In children, the tumor is usually located in the cerebellum and will present with some combination of vision deterioration (which is typically uncorrectable by glasses), gait instability, unilateral ataxia, and signs of increased intracranial pressure (headache, vomiting).
Children with astrocytoma usually have decreased memory, attention, and motor abilities, but unaffected intelligence, language, and academic skills. [3] When metastasis occurs, it can spread via the lymphatic system, causing death even when the primary tumor is well controlled.[4]
Diagnosis
A Computed Tomography (CT) or Magnetic Resonance Imaging (MRI) scan is necessary to characterize the anatomy of this tumor (size, location, consistency). CT will usually show distortion of third and lateral ventricles with displacement of anterior and middle cerebral arteries.
Histologic diagnosis with tissue biopsy will normally reveal an infiltrative character suggestive of the slow growing nature of the tumor. The tumor may be cavitating, pseudocyst-forming, or noncavitating. Appearance is usually white-gray, firm, and almost indistinguishable from normal white matter.
Treatment
Resection of the tumor will generally allow functional survival for many years. In recent reports, the 5 year survival has been over 90% with well resected tumors. These tumors will eventually undergo malignant transformation and addition of radiation therapy or chemotherapy will be necessary. Astrocytomas often recur even after treatment and are usually treated similarly as the initial tumor, with sometimes more aggressive chemotherapy or radiation therapy. In some rare cases, the tumor creates two or more cell types, and treatment may kill one cell type while allowing the other to become more aggressive and immune to future treatments.
References
- ↑ M Toda et al (1994). "Cell growth suppression of astrocytoma C6 cells by glial fibrillary acidic protein cDNA transfection". Journal of Neurochemistry 63 (5): 1975-1978. PMID 7931355.
- ↑ JHN Deck et al (1978). "The role of glial fibrillary acidic protein in the diagnosis of central nervous system tumors". Acta Neuropathologica 42 (3): 183-190. Springer Berlin / Heidelberg. doi:10.1007/BF00690355.
- ↑ JL Ater et al (1996). "Correlation of medical and neurosurgical events with neuropsychological status in children at diagnosis of astrocytoma: utilization of a neurological severity score". Journal of Child Neurology 11 (6): 462-469. PMID 9120225.
- ↑ JM Dewar, PJ Dady and V Balakrishnan (1985). "Metastatic astrocytoma". Australian and New Zealand Journal of Medicine 15 (6): 745-747. PMID 3010926.
See also
- glioma
- brain tumor
- pilocytic astrocytoma
- glioblastoma multiforme
- intracranial pressure
- Histopathologic video of low grade astrocytoma
Nervous tissue tumors (ICD-O 9350-9589) | |
|---|---|
| Miscellaneous tumors (9350-9379) | Craniopharyngioma - Pinealoma - Chordoma |
| Glioma (9380-9489) | Gliomatosis cerebri - Oligoastrocytoma - Choroid plexus papilloma - Ependymoma - Astrocytoma (Pilocytic astrocytoma, Glioblastoma multiforme) - Dysembryoplastic neuroepithelial tumour - Oligodendroglioma - Medulloblastoma - Primitive neuroectodermal tumor |
| Neuroepitheliomatous (9490-9529) | Ganglioneuroma - Neuroblastoma - Atypical teratoid rhabdoid tumor - Retinoblastoma - Esthesioneuroblastoma |
| Meningiomas (9530-9539) | Meningioma |
| Nerve sheath tumor (9540-9579) | Neurofibroma (Neurofibrosarcoma, Neurofibromatosis) - Schwannoma - Neurinoma - Acoustic neuroma - Neuroma |
| see also brain tumors (though not all brain tumors are of nervous tissue) | |
Acknowledgement and Attribution Regarding Sources of Content
Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .
